A detailed history of Rock Springs Capital Management LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Rock Springs Capital Management LP holds 505,786 shares of LEGN stock, worth $20.2 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
505,786
Previous 499,486 1.26%
Holding current value
$20.2 Million
Previous $28 Million 20.04%
% of portfolio
0.69%
Previous 0.73%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $248,850 - $360,486
6,300 Added 1.26%
505,786 $22.4 Million
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $387,732 - $492,869
7,042 Added 1.43%
499,486 $28 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $1.96 Million - $2.38 Million
34,179 Added 7.46%
492,444 $29.6 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $338,632 - $447,428
7,799 Added 1.73%
458,265 $22.1 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $3.62 Million - $5.42 Million
94,899 Added 26.69%
450,466 $18.4 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $55.0 $1.87 Million - $3.06 Million
-55,617 Reduced 13.53%
355,567 $19.6 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $235,752 - $366,168
7,600 Added 1.88%
411,184 $14.9 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $3.64 Million - $5.04 Million
88,366 Added 28.03%
403,584 $18.8 Million
Q3 2021

Nov 15, 2021

BUY
$35.31 - $50.56 $91,806 - $131,456
2,600 Added 0.83%
315,218 $15.9 Million
Q1 2021

May 17, 2021

BUY
$23.55 - $32.4 $75,360 - $103,680
3,200 Added 1.03%
312,618 $9.07 Million
Q4 2020

Feb 16, 2021

BUY
$25.8 - $32.39 $1.48 Million - $1.86 Million
57,280 Added 22.72%
309,418 $8.71 Million
Q3 2020

Nov 16, 2020

BUY
$27.5 - $39.61 $1.27 Million - $1.83 Million
46,242 Added 22.46%
252,138 $7.78 Million
Q2 2020

Aug 14, 2020

BUY
$36.1 - $42.56 $7.43 Million - $8.76 Million
205,896 New
205,896 $8.76 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.